The Food and Drug Administration recently approved Pivya (pivmecillinam) to treat uncomplicated UTIs in female adults.
The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract ...
The approval was based on data from 3 phase 3 trials which compared the efficacy of different dosing regimens of ...
"The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will ...
For the first time in two decades, a new pill for urinary tract infections has been approved in hopes of combating bugs that are resistant to antibiotics. The FDA has approved the drug ...
The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (UTIs) caused by ...
More than 50% of the patients who used a new mouth-spray-based vaccine didn't have a UTI for up to nine years.
Researchers are developing vaccines and fresh drug approaches to prevent and treat recurring infections without antibiotics.
Bactrim (sulfamethoxazole/trimethoprim) is a brand-name drug that’s prescribed for certain infections. Bactrim comes as a tablet. The dosage can vary depending on ...
A stinging sensation when you pee, cramping in your lower belly, an intense urge to tinkle all day long. Anyone who’s ever ...
The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (UTIs) caused ...
More than 50% of the patients who used a new mouth-spray-based vaccine didn't have a UTI for up to nine years. Comments (0) In early trials, a new vaccine for recurrent UTIs has shown promise.